DENISE BROOKS: Open Payments
NPI 1124257365 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,305 in 148 payments from 15 companies in 2025. Trend: 2023 $216 · 2024 $799 · 2025 $3,305
Food & beverage: $3,111Education: $194
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $568 |
| Novartis Pharmaceuticals Corporation | 14 | $486 |
| Janssen Biotech, Inc. | 18 | $396 |
| Incyte Corporation | 12 | $296 |
| UCB, Inc. | 10 | $241 |
| Galderma Laboratories, L.P. | 26 | $237 |
| GENZYME CORPORATION | 9 | $222 |
| Arcutis Biotherapeutics, Inc. | 4 | $207 |
| Amgen Inc. | 9 | $188 |
| Lilly USA, LLC | 10 | $168 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, OPZELURA, Bimzelx, Zoryve, OTEZLA, RINVOQ.
Industry payments across VA — which companies pay providers there.
